The nature and consequence of genetic variability within Mycobacterium tuberculosis

作者: M. Kato-Maeda , P.J. Bifani , B.N. Kreiswirth , P.M. Small

DOI: 10.1172/JCI11426

关键词:

摘要: Viewed in terms of its historical and contemporary disease burden, Mycobacterium tuberculosis (MTB) is undeniably the most successful human pathogen. Molecular paleoarchaeologic evidence clearly identified MTB as cause lesions 5,000-year-old mummies. Over recorded history, burden has been staggering. In Europe mortality was between 200 300 per 100,000 at beginning 19th century. Today, still remains an important morbidity displaced from position leading infectious death only by accounting policies World Health Organization, which attribute deaths to immunodeficiency virus increasing number coinfected persons. The future not brighter. optimistic scenarios predict excess 80 million new cases 20 coming decade, 95% will occur resource-poor countries. After decades neglect, a resurgence industrialized countries reinvigorated research efforts, now back on cutting edge science. epidemiologic approaches have provided novel insights into transmission dynamics helped refocus refine control practices. These studies highlighted old that there significant variability clinical consequences infection with MTB. near future, mycobacteria are likely be one deeply sequenced pathogenic groups. complete genomes two isolates available, sequencing M. bovis, bacille Calmette-Guerin (BCG), smegmatis, paratuberculosis, leprae, marinum, ulcerans, avium somewhere contemplated completed. Although much known about environmental host factors contribute variability, little know bacteria’s role. Given recent advances, we poised explore nature genetic Here, review data supporting phenotypic genotypic diversity laboratory natural strains our understanding relationship them.

参考文章(36)
Sultan L, Mills C, O'grady F, Riley Rl, Wells W, Nyka W, Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients. The American review of respiratory disease. ,vol. 82, pp. 358- ,(1960) , 10.1164/ARRD.1960.82.3.358
Remold Hg, Balcewicz-Sablinska Mk, Keane J, Kornfeld H, Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha Journal of Immunology. ,vol. 161, pp. 2636- 2641 ,(1998)
Abdul-Ilah Alsaadi, Donald W. Smith, The fate of virulent and attenuated Mycobacteria in guinea pigs infected by the respiratory route. The American review of respiratory disease. ,vol. 107, pp. 1041- ,(1973) , 10.1164/ARRD.1973.107.6.1041
L K Marchiando, T M Kaufman, L S Schlesinger, S Iyer, S R Hull, Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. Journal of Immunology. ,vol. 157, pp. 4568- 4575 ,(1996)
F Chaves, Z Yang, H el Hajj, M Alonso, W J Burman, K D Eisenach, F Dronda, J H Bates, M D Cave, Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. Journal of Clinical Microbiology. ,vol. 34, pp. 1118- 1123 ,(1996) , 10.1128/JCM.34.5.1118-1123.1996
L Pascopella, F M Collins, J M Martin, M H Lee, G F Hatfull, C K Stover, B R Bloom, W R Jacobs, Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infection and Immunity. ,vol. 62, pp. 1313- 1319 ,(1994) , 10.1128/IAI.62.4.1313-1319.1994
Liana Tsenova, Claudia Manca, Victoria H. Freedman, Patrick A.J. Haslett, Sherry Freeman, Clifton E. Barry, Amy Bergtold, Gilla Kaplan, James M. Musser, Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates Journal of Immunology. ,vol. 162, pp. 6740- 6746 ,(1999)
Sylvie Poulet, Stewart T. Cole, Repeated DNA sequences in mycobacteria. Archives of Microbiology. ,vol. 163, pp. 79- 86 ,(1995) , 10.1007/BF00381780
Peter F. Barnes, Patterns of Tuberculosis Transmission in Central Los Angeles JAMA: The Journal of the American Medical Association. ,vol. 278, pp. 1159- 1163 ,(1997) , 10.1001/JAMA.1997.03550140051039